News Daily


Men's Weekly

News from Asia

  • Written by Media Outreach
BANGKOK, THAILAND - Media OutReach Newswire - 27 May 2025 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounjaro® (tirzepatide), the innovative obesity and diabetes medicine developed by Eli Lilly and Company, will be launched in Thailand at the end of May 2025. Zuellig Pharma holds the marketing authorization for Mounjaro® (tirzepatide) in Thailand, having been granted the distribution and promotion rights for the medicine by Eli Lilly and Company this year.

Mounjaro® (tirzepatide) is a once-weekly prescription-only medicine indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise; as monotherapy when metformin is considered inappropriate due to intolerance or contraindications, in addition to other medicinal products for the treatment of diabetes; and as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial Body Mass Index (BMI) of ≥30 kg/m2 (obesity) or ≥27 kg/m2 to < 30 kg/m2 (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease, prediabetes, or type 2 diabetes mellitus).

The availability of Mounjaro® (tirzepatide) is a significant advancement in the treatment of both obesity and type 2 diabetes, offering a single medication that can address both conditions through an easy-to-use prefilled pen. Mounjaro® KwikPen® (tirzepatide injection) is available in 2.5 mg, 5 mg, 7.5 mg and 10 mg, and gives healthcare providers the ability to personalize treatment plans better to meet individual patient needs.

Obesity is a critical public health concern in Thailand that affects 48% of the total population.2 The Ministry of Public Health classifies obesity as a Non-Communicable Disease (NCD) due to its strong link to rising rates for chronic illnesses, particularly type 2 diabetes. In 2024, the Department of Disease Control reported that 1 in 10 Thai individuals – a total of 6.5 million people – suffer from type 2 diabetes, impacting their physical, mental, and social well-being.2

People with diabetes face significant challenges in managing their blood sugar and preventing complications such as cardiovascular disease, chronic kidney disease, diabetic retinopathy, and diabetic foot ulcers, which can lead to severe infections and potential amputation.3

"Obesity and diabetes have gained prominence as significant health challenges in Thailand, and we are excited to accelerate the availability of Mounjaro® (tirzepatide) to patients in the region. With our deep understanding of the local regulatory landscape, as well as our proven track record of delivering innovative healthcare solutions in unmet disease areas, we are well placed to enhance the availability of the medicine in the market. This represents a significant step forward in our commitment to making healthcare more accessible, particularly in the chronic metabolic disease market," said Rehan Saghir, Executive Vice President of Zuellig Pharma's Commercialization division.

References:

  1. Mounjaro. Prescribing Information. Eli Lilly Asia, Inc.
  2. Division of Non-communicable Disease, Department of Disease Control, Ministry of Public Health)
  3. Yang, T., Qi, F., Guo, F. et al. An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory. Mol Med 30, 71 (2024). https://doi.org/10.1186/s10020-024-00824-9

Hashtag: #ZuelligPharma #EliLillyandCompany #Diabetes #Obesity #Healthcare #Pharmaceuticals

The issuer is solely responsible for the content of this announcement.

Read more

Top Electrical Safety Tips from Inner West Sydney Electricians

While it may not be the most exciting subject to discuss, having an electrically safe home is definitely one of the most critical. Knowing the basics could help you avoid accidents and ensure your home remains in good condition, whether... Read more

When to Escalate a Debt Recovery Matter to Legal Action

Knowing when to transition from informal debt collection efforts to formal legal proceedings is a decision that many creditors find difficult to navigate. Acting too early can damage commercial relationships, while waiting too long can reduce the likelihood of recovery... Read more

Why Slurry Hose Systems Are Essential for Handling Abrasive Industrial Materials

Transporting abrasive mixtures is a common challenge in industries such as mining, dredging, and construction. These mixtures, known as slurry, consist of solid particles suspended in water or other liquids. Moving slurry through pipelines requires specialised equipment that can withstand... Read more

Why Choosing the Right Dental Clinic Matters for Long Term Oral Health

Maintaining good oral health requires regular checkups, preventive care, and professional treatment when needed. Visiting a trusted Dental Clinic plays a vital role in keeping teeth and gums healthy while preventing more serious dental problems in the future. Many people only... Read more

Is Deep Plane Facelift Safe in Thailand?

When you ask whether a deep plane facelift is safe in Thailand, you’re really asking: “Can I get high-quality surgical care with strong safety standards and reliable follow-up while I’m traveling?” That’s a smart question. But the country name alone... Read more

Why Cloud Services Are Now Essential for Business Growth and Security

In today’s fast-moving digital environment, understanding how cloud services support long-term stability has become a priority for businesses across Australia. As expectations shift and workplaces adopt more flexible models, organisations are turning to cloud services to keep systems running smoothly... Read more